Log in
Enquire now
‌

US Patent 10398646 Methods for treating lung disorders

Patent 10398646 was granted and assigned to CritiTech on September, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
CritiTech
CritiTech
Current Assignee
CritiTech
CritiTech
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10398646
Date of Patent
September 3, 2019
Patent Application Number
16007095
Date Filed
June 13, 2018
Patent Citations Received
‌
US Patent 12128131 Treatment of epithelial cysts by intracystic injection of antineoplastic particles
0
‌
US Patent 11583499 Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
‌
US Patent 11918691 Local delivery of antineoplastic particles in combination with systemic delivery of immunotherapeutic agents for the treatment of cancer
0
‌
US Patent 11458133 Methods for solid tumor treatment
‌
US Patent 11523983 Treatment of epithelial cysts by intracystic injection of antineoplastic particles
Patent Primary Examiner
‌
Robert A Wax
Patent abstract

Disclosed herein are compositions and methods for treating lung disorders including lung tumors by pulmonary administration of compositions comprising taxane particles such as docetaxel or paclitaxel particles.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 10398646 Methods for treating lung disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.